Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,188 | 19,743 | 27,204 | 28,906 | 29,801 |
| TOTAL | $17,188 | $19,743 | $27,204 | $28,906 | $29,801 |
| Non-Current Assets | |||||
| Intangibles | 11 | 12 | 13 | 14 | 14 |
| TOTAL | $11 | $12 | $13 | $14 | $14 |
| Total Assets | $17,199 | $19,755 | $27,217 | $28,920 | $29,815 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 221 | 221 | 221 | 296 | 628 |
| Other current liabilities | 8 | 20 | 164 | 159 | 25 |
| TOTAL | $229 | $241 | $385 | $455 | $653 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $229 | $241 | $385 | $455 | $653 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,824 | 13,000 | 12,951 | 13,123 | 12,969 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -36,363 | -35,617 | -33,648 | -31,287 | -30,424 |
| TOTAL | $16,970 | $19,514 | $26,832 | $28,464 | $29,163 |
| Total Liabilities And Equity | $17,199 | $19,755 | $27,217 | $28,920 | $29,815 |